Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”

Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon

Clin Mol Hepatol. 2024;30(4):659-662. Published online July 17, 2024

DOI: https://doi.org/10.3350/cmh.2024.0516

View: 929 Download: 74

Original Article

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee

Clin Mol Hepatol. 2016;22(1):160-167. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.160

View: 11896 Download: 199 Web of Science: 81 Crossref: 72

4

A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy

Ik Yoon, M.D., Hyung Joon Yim, M.D., Jin Nam Kim, M.D., Sun Min Park, M.D., Jeong Han Kim, M.D., Seung Hwa Lee, M.D. Hwan Hoon Chung, M.D. Hong Sik Lee, M.D., Sang Woo Lee, M.D., Jai Hyun Choi, M.D.

Clin Mol Hepatol. 2009;15(1):90-95. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.90

View: 4722 Download: 44 Crossref: 1

3

Efficacy of Transarterial Chemolipiodolization with or without 3-Dimensional Conformal Radiotherapy for Huge HCC with Portal Tumor Thrombosis

Chan Ran You, M.D., Jeong Won Jang, M.D., Seok Hui Kang, M.D., Si Hyun Bae, M.D., Jong Young Choi, M.D., Seung Kew Yoon, M.D., Ihl Bhong Choi, M.D. Dong Hoon Lee, M.D. Ho Jong Chun, M.D. Byung Gil Choi, M.D.

Clin Mol Hepatol. 2007;13(3):378-386. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.378

View: 5084 Download: 55 Crossref: 13

Correspondence

Correspondence on Letter regarding “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”

Moon Haeng Hur, Yoon Jun Kim

Received October 25, 2024 Accepted November 1, 2024

DOI: https://doi.org/10.3350/cmh.2024.0943 [Accepted]

View: 230 Download: 13

1 |

Viewed By 5112	MAFLD: How is it different from NAFLD?
Viewed By 5074	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4512	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4489	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4377	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 114	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search